Intel Corp (INTC) Stock Price Today
FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patients
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Industrial sector sentiment hits 5-year high on strong demand and capex optimism
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
Oil prices rise amid US-Iran tensions over potential strikes on Iran's infrastructure
Oil prices increased as tensions escalated between the US and Iran, with Iran threatening to retaliate against regional infrastructure if the US strikes its key facilities. US West Texas Intermediate futures rose 1.32% to $80.09 per barrel, while Bre...
Law firm probes Travere Therapeutics officers for possible self-dealing harming shareholders
Kuehn Law, PLLC is investigating whether certain officers and directors of Travere Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. The probe could lead to damages and governance reforms benefiting shareholders. Long...
Law firm probes Viking Therapeutics officers for possible self-dealing harming shareholders
Kuehn Law, PLLC is investigating whether certain officers and directors of Viking Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal inquiry could lead to shareholder damages and corporate governance reforms...
BBVA economists discuss global macro outlook and core market challenges in strategic talk.
BBVA held a strategic session where its chief economists shared insights on the global macroeconomic environment and the outlook for key markets including Spain, Mexico, and Turkey. The discussion highlighted recent economic developments, challenges,...
Law firm investigates TG Therapeutics officers for possible self-dealing harming shareholders
Kuehn Law, PLLC is investigating whether certain officers and directors of TG Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and corporate governance reforms....
Law firm probes Quantum Computing Inc. officers for possible shareholder duty breaches
Kuehn Law, PLLC is investigating whether officers and directors of Quantum Computing Inc. breached their fiduciary duties through potential self-dealing. The investigation could lead to shareholder damages and corporate governance reforms. Long-term ...
Law firm probes Rhythm Pharmaceuticals officers for possible self-dealing harming shareholders
Kuehn Law, PLLC is investigating whether officers and directors of Rhythm Pharmaceuticals, Inc. breached their fiduciary duties through potential self-dealing. The investigation could lead to damages for shareholders and reforms in corporate governan...
Japanese AI-linked tech stocks fall sharply amid global semiconductor sell-off
Japanese technology stocks, including SoftBank and Tokyo Electron, dropped significantly following a steep decline in U.S. semiconductor shares. The sell-off was driven by concerns over AI spending and a recent patent infringement ruling against Kiox...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.